RMED - Ra Medical Systems, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD

Ra Medical Systems, Inc.

2070 Las Palmas Drive
Carlsbad, CA 92011
United States

IndustryMedical Devices
Full Time Employees114

Key Executives

NameTitlePayExercisedYear Born
Mr. Jeffrey Jay KrawsPres462.1kN/A1964
Mr. Dean IrwinChief Technology Officer & Director467.31kN/A1963
Mr. Andrew C. JacksonInterim CEO, Principal Exec. Officer & CFON/AN/A1969
Ms. Melissa BursteinExec. VPN/AN/A1976
Mr. Daniel HorwoodGen. Counsel & Sec.N/AN/A1974
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.

Corporate Governance

Ra Medical Systems, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.